A detailed history of New York State Common Retirement Fund transactions in Editas Medicine, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 4,394 shares of EDIT stock, worth $5,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,394
Previous 28,794 84.74%
Holding current value
$5,316
Previous $134,000 88.81%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$3.39 - $5.96 $82,716 - $145,424
-24,400 Reduced 84.74%
4,394 $15,000
Q2 2024

Jul 31, 2024

SELL
$4.67 - $7.28 $26,973 - $42,049
-5,776 Reduced 16.71%
28,794 $134,000
Q1 2024

May 07, 2024

BUY
$7.03 - $11.07 $66,271 - $104,356
9,427 Added 37.49%
34,570 $257,000
Q4 2023

Feb 01, 2024

SELL
$6.25 - $11.11 $768 - $1,366
-123 Reduced 0.49%
25,143 $255,000
Q3 2023

Nov 07, 2023

BUY
$6.92 - $9.31 $2,733 - $3,677
395 Added 1.59%
25,266 $197,000
Q2 2023

Aug 07, 2023

SELL
$6.36 - $11.47 $93,434 - $168,505
-14,691 Reduced 37.13%
24,871 $205,000
Q1 2023

May 02, 2023

SELL
$7.03 - $11.53 $68,422 - $112,221
-9,733 Reduced 19.74%
39,562 $287,000
Q4 2022

Jan 30, 2023

SELL
$8.32 - $13.21 $49 - $79
-6 Reduced 0.01%
49,295 $437,000
Q3 2022

Nov 08, 2022

BUY
$12.16 - $19.42 $1,179 - $1,883
97 Added 0.2%
49,301 $603,000
Q2 2022

Aug 04, 2022

SELL
$9.99 - $21.35 $829 - $1,772
-83 Reduced 0.17%
49,204 $582,000
Q1 2022

May 05, 2022

SELL
$14.08 - $27.63 $146,319 - $287,130
-10,392 Reduced 17.41%
49,287 $937,000
Q4 2021

Feb 02, 2022

SELL
$26.55 - $40.57 $7,619 - $11,643
-287 Reduced 0.48%
59,679 $1.58 Million
Q3 2021

Nov 02, 2021

SELL
$39.27 - $72.94 $358,456 - $665,796
-9,128 Reduced 13.21%
59,966 $2.46 Million
Q2 2021

Aug 02, 2021

SELL
$31.29 - $56.64 $35,952 - $65,079
-1,149 Reduced 1.64%
69,094 $3.91 Million
Q4 2020

Feb 08, 2021

BUY
$27.07 - $84.35 $152,945 - $476,577
5,650 Added 8.75%
70,243 $4.93 Million
Q3 2020

Nov 05, 2020

BUY
$28.06 - $37.16 $266,570 - $353,019
9,500 Added 17.24%
64,593 $1.81 Million
Q2 2020

Aug 07, 2020

BUY
$18.5 - $34.34 $59,200 - $109,888
3,200 Added 6.17%
55,093 $1.63 Million
Q4 2019

Feb 05, 2020

SELL
$19.49 - $32.63 $101,347 - $169,676
-5,200 Reduced 9.11%
51,893 $1.54 Million
Q3 2019

Nov 07, 2019

BUY
$22.49 - $26.81 $15,742 - $18,767
700 Added 1.24%
57,093 $1.3 Million
Q2 2019

Aug 09, 2019

BUY
$20.48 - $27.76 $161,792 - $219,304
7,900 Added 16.29%
56,393 $1.4 Million
Q1 2019

May 08, 2019

SELL
$19.43 - $26.41 $4,857 - $6,602
-250 Reduced 0.51%
48,493 $1.19 Million
Q4 2018

Feb 08, 2019

SELL
$18.19 - $31.79 $112,778 - $197,098
-6,200 Reduced 11.28%
48,743 $1.11 Million
Q3 2018

Nov 07, 2018

SELL
$27.65 - $38.39 $1,382 - $1,919
-50 Reduced 0.09%
54,943 $1.75 Million
Q2 2018

Aug 10, 2018

BUY
$31.4 - $41.01 $295,160 - $385,494
9,400 Added 20.62%
54,993 $1.97 Million
Q1 2018

May 10, 2018

BUY
$29.84 - $44.08 $89,520 - $132,240
3,000 Added 7.04%
45,593 $1.51 Million
Q4 2017

Feb 13, 2018

SELL
$21.89 - $31.34 $236,039 - $337,939
-10,783 Reduced 20.2%
42,593 $1.31 Million
Q3 2017

Nov 06, 2017

BUY
$15.81 - $24.01 $273,133 - $414,796
17,276 Added 47.86%
53,376 $1.28 Million
Q2 2017

Aug 11, 2017

BUY
N/A
36,100
36,100 $606,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $83.2M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.